Calliditas Therapeutics saw the highest growth of 0.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Calliditas Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Calliditas Therapeutics has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The United States(US) patent Office are among the top ten patent offices where Calliditas Therapeutics is filings its patents. Among the top granted patent authorities, Calliditas Therapeutics has 100% of its grants in United States(US).
Roche and Johnson & Johnson could be the strongest competitors for Calliditas Therapeutics
Patents related to rare diseases and immuno-oncology lead Calliditas Therapeutics's portfolio
Calliditas Therapeutics has the highest number of patents in rare diseases followed by, immuno-oncology. For rare diseases, nearly 100% of patents were filed and 50% of patents were granted in Q2 2024.
Iga nephropathy (berger's disease) related patents lead Calliditas Therapeutics portfolio followed by breast cancer, and glioblastoma multiforme (gbm)
Calliditas Therapeutics has highest number of patents in iga nephropathy (berger's disease) followed by breast cancer, glioblastoma multiforme (gbm), bladder cancer, and solid tumor.
For comprehensive analysis of Calliditas Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
